Literature DB >> 12722136

Antiangiogenic activity of lupeol from Bombax ceiba.

Young-Jae You1, Nguyen-Hai Nam, Yong Kim, Ki-Hwan Bae, Byung-Zun Ahn.   

Abstract

In the search for antiangiogenic agents from medicinal plants used in Vietnam, a methanol extract of the stem barks of Bombax ceiba was found to exhibit a significant antiangiogenic activity on in vitro tube formation of human umbilical venous endothelial cells (HUVEC). Bioactivity-guided fractionation and isolation carried out on this extract afforded lupeol as an active principle. At 50 and 30 microg/mL lupeol showed a marked inhibitory activity on HUVEC tube formation while it did not affect the growth of tumor cell lines such as SK-MEL-2, A549, and B16-F10 melanoma. Copyright 2003 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12722136     DOI: 10.1002/ptr.1140

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  23 in total

1.  Mechanism of inhibition of ascites tumor growth in mice by curcumin is mediated by NF-kB and caspase activated DNase.

Authors:  Madesh Belakavadi; Bharathi P Salimath
Journal:  Mol Cell Biochem       Date:  2005-05       Impact factor: 3.396

2.  Specific targeting of Wnt/β-catenin signaling in human melanoma cells by a dietary triterpene lupeol.

Authors:  Rohinton S Tarapore; Imtiaz A Siddiqui; Mohammad Saleem; Vaqar M Adhami; Vladimir S Spiegelman; Hasan Mukhtar
Journal:  Carcinogenesis       Date:  2010-08-23       Impact factor: 4.944

3.  The dietary terpene lupeol targets colorectal cancer cells with constitutively active Wnt/β-catenin signaling.

Authors:  Rohinton S Tarapore; Imtiaz A Siddiqui; Vaqar M Adhami; Vladimir S Spiegelman; Hasan Mukhtar
Journal:  Mol Nutr Food Res       Date:  2013-07-09       Impact factor: 5.914

4.  Lupeol enhances inhibitory effect of 5-fluorouracil on human gastric carcinoma cells.

Authors:  Yan Liu; Tingting Bi; Wei Dai; Gang Wang; Liqiang Qian; Genhai Shen; Quangen Gao
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-02-19       Impact factor: 3.000

5.  Antiangiogenic activity of PLGA-Lupeol implants for potential intravitreal applications.

Authors:  Daniel Crístian Ferreira Soares; Diogo Coelho de Paula Oliveira; Luciola Silva Barcelos; Alan Sales Barbosa; Lorena Carla Vieira; Danyelle M Townsend; Domenico Rubello; André Luis Branco de Barros; Lucienir Pains Duarte; Armando Silva-Cunha
Journal:  Biomed Pharmacother       Date:  2017-05-27       Impact factor: 6.529

6.  Lupeol inhibits proliferation and induces apoptosis of human pancreatic cancer PCNA-1 cells through AKT/ERK pathways.

Authors:  Yan Liu; Tingting Bi; Gang Wang; Wei Dai; Guoliang Wu; Liqiang Qian; Quangen Gao; Genhai Shen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-11-25       Impact factor: 3.000

7.  Lupeol induces apoptosis and inhibits invasion in gallbladder carcinoma GBC-SD cells by suppression of EGFR/MMP-9 signaling pathway.

Authors:  Yan Liu; Tingting Bi; Genhai Shen; Zhimin Li; Guoliang Wu; Zheng Wang; Liqiang Qian; Quangen Gao
Journal:  Cytotechnology       Date:  2014-07-19       Impact factor: 2.058

8.  Lupane triterpenes with a carbonyl group at C-20 induce cancer cell apoptosis.

Authors:  Keishi Hata; Shoujiro Ogawa; Mitsuko Makino; Toshiyuki Mukaiyama; Kazuyuki Hori; Takashi Iida; Yasuo Fujimoto
Journal:  J Nat Med       Date:  2008-03-14       Impact factor: 2.343

9.  Neuroblastoma SH-SY5Y cytotoxicity, anti-amyloidogenic activity and cyclooxygenase inhibition of Lasianthus trichophlebus (Rubiaceae).

Authors:  Mario A Tan; Mark Wilson D Lagamayo; Grecebio Jonathan D Alejandro; Seong Soo A An
Journal:  3 Biotech       Date:  2020-03-03       Impact factor: 2.406

Review 10.  Lupeol, a novel anti-inflammatory and anti-cancer dietary triterpene.

Authors:  Mohammad Saleem
Journal:  Cancer Lett       Date:  2009-05-22       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.